Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Patent expiry trametinib?
Bivalirudin manufacturer?
Novartis patent term dabrafenib?
When oxcarbazepine patent expired?
Are there income restrictions for lipitor's patient program?

Fda approval date acalabrutinib?

See the DrugPatentWatch profile for acalabrutinib

FDA first approved acalabrutinib (Calquence) on January 31, 2017, for mantle cell lymphoma after at least one prior therapy. If you’d like, I can provide a full timeline of all subsequent FDA approvals and their indications.



Other Questions About Acalabrutinib :

Acalabrutinib fda approval cll? Acalabrutinib fda approval october 2017 calquence? Acalabrutinib patent expiry? Acalabrutinib cost? Acalabrutinib manufacturer? Acalabrutinib fda approval october 2017? Acalabrutinib fda approval date 2017?